WaveMan
WaveMan · Company
BCAT · Blackrock Capital Allocation Term Trust
> Search tickers & screens ⌘K
LIVE
← All companies

BCAT BlackRock Capital Allocation Term Trust (BCAT) Insider Trading, Ownership & Congress Trades

Funds & Trusts · Registered investment company · CIK 0001809541
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter

What the filings say about BCAT

Insiders, 180 days
-$570.3K net sold
1 seller · 0% of sales under a 10b5-1 plan

BlackRock Capital Allocation Term Trust insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, BlackRock Capital Allocation Term Trust insiders sold a net $570.3K of stock across 205 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
SELL
2026-07-15 SECtraded 2026-07-13
35,734
$570.3K
-13.7%
Context
  • 25 earlier Form 4 trades (code P or S) here by this insider (24 buys, 1 sale), the last on Jul 5, 2023.
  • -2.9% median (-0.3% mean) 90-day return after 4 previous buys.
  • The trade is 13.1% of the 272,353 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Insider Rieder Richard M sold about $570.3K of BCAT on Jul 13, 2026, the largest insider sale at the company since 2025.
SELL
2025-05-19 SECtraded 2025-05-16
129,204
$1.9M
+17.2%
Context
  • 76 earlier Form 4 trades (code P or S) here by this insider (25 buys, 51 sales), the last on May 15, 2025.
  • +7.1% median (+6.4% mean) 90-day return after 25 previous buys.
  • The trade is 1.2% of the 10,389,562 shares held after it.
  • 1 other insider sold within 30 days.
Insider activity: Insider Weinstein Boaz sold about $1.9M of BCAT on May 16, 2025; 1 other insider sold within 30 days.
SELL
2025-05-19 SECtraded 2025-05-15
55,335
$825.0K
+17.2%
Context
  • 75 earlier Form 4 trades (code P or S) here by this insider (25 buys, 50 sales), the last on May 14, 2025.
  • +7.1% median (+6.4% mean) 90-day return after 25 previous buys.
  • The trade is 0.5% of the 10,518,766 shares held after it.
  • 1 other insider sold within 30 days.
Insider activity: Insider Weinstein Boaz sold about $825.0K of BCAT on May 15, 2025; 1 other insider sold within 30 days.
SELL
2025-05-15 SECtraded 2025-05-14
111,025
$1.7M
+16.3%
Context
  • 74 earlier Form 4 trades (code P or S) here by this insider (25 buys, 49 sales), the last on May 13, 2025.
  • +7.1% median (+6.4% mean) 90-day return after 25 previous buys.
  • The trade is 1.0% of the 10,574,101 shares held after it.
  • 1 other insider sold within 30 days.
Insider activity: Insider Weinstein Boaz sold about $1.7M of BCAT on May 14, 2025; 1 other insider sold within 30 days.
SELL
2025-05-15 SECtraded 2025-05-13
175,794
$2.7M
+16.3%
Context
  • 73 earlier Form 4 trades (code P or S) here by this insider (25 buys, 48 sales), the last on May 9, 2025.
  • +7.1% median (+6.4% mean) 90-day return after 25 previous buys.
  • The trade is 1.6% of the 10,685,126 shares held after it.
  • 1 other insider sold within 30 days.
Insider activity: Insider Weinstein Boaz sold about $2.7M of BCAT on May 13, 2025; 1 other insider sold within 30 days.
205 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Showing the latest few. to see 200 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$570.3K over 180 days
below 92% of Funds & Trusts
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
2.9 days to cover · settled 2026-09-30
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch BCAT

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+9.8%12M
-2%+9%+21%+32%2025-102025-122026-022026-042026-062026-082026-10 2026-07-13 · Rieder Richard M sold $570.3K
Insider sell
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns BCAT: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in BCAT

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

BCAT planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $570.3K sold by insiders over 180 days. Each figure is a federal filing, dated the day it went public.
Same sector, ranked by filing activity
Sector by SEC SIC code

BCAT Stock Sonar score 1/7 axes

Find similar shapesCompare
Insider conviction
4
Inputs
  • Net Form 4 buying (codes P and S), 180d-$570K · 7 pct, sector of 142
  • Insider buyers, 180d0 · 0 pct, sector of 142
6 not measured: Profitability, Financial health, Growth, Institutional and government, Risk and compliance, US patents
  • Profitability needs 2 of 4 inputs, 0 present: not filed
  • Financial health needs 1 of 2 inputs, 0 present: not filed
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • Risk and compliance needs 1 of 4 inputs, 0 present: needs two 10-Ks with a Risk Factors section (not 20-F filers or stubs); no short interest or no free float on file; revenue under $50M or not filed, so a count cannot be scaled to size
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

1 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

BCAT filings, in plain words

Are BlackRock Capital Allocation Term Trust insiders buying or selling BCAT?

In the 180 days to 2026-10-27, BlackRock Capital Allocation Term Trust insiders were net sellers, a net $570.3K across purchases and sales reported on Form 4, by 1 seller.

Read the full summary

In the 180 days to 2026-10-27, BlackRock Capital Allocation Term Trust insiders were net sellers of BCAT, a net $570.3K across purchases and sales reported on Form 4 by 1 seller. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing